ÃÛÌÒÖ±²¥

Your web browser is outdated and may be insecure

The RCN recommends using an updated browser such as or

Administering Subcutaneous Methotrexate for Inflammatory Arthritis

Published: 19/10/2021
Last updated: 18/10/2021
Publication code: 009 675

This guidance provides the background information regarding subcutaneous methotrexate as an educational resource for practitioners, with particular reference to safety and best practice; and incorporates new sections on treat-to-target and medication optimisation. Whilst the guidance has been developed for rheumatology practitioners, some aspects may also be of value to health care colleagues working in other specialties including dermatology, gastroenterology and ophthalmology. This publication is supported by grants from Accord, Medac and Nordic.

Some of our publications are also available in hard copy, but this may entail a small charge. For more information and to order a hard copy please call 0345 772 6100 and select option five. The line is open Monday-Friday (excluding bank holidays) between 10am-4pm.

You can download all electronic publications from the RCN free of charge.

Published by the ÃÛÌÒÖ±²¥, 20 Cavendish Square, London, W1G 0RN.

© 2016 ÃÛÌÒÖ±²¥. This publication in hard copy format may not be lent, resold, hired out or otherwise disposed of by way of trade in any form of binding or cover other than that in which it is published, without the prior consent of the publishers.

For permission to reproduce RCN copyrighted text, please complete our copyright request form.

Page last updated - 19/03/2022